NLM Digital Collections

Search

Start Over Subjects Antibodies, Monoclonal -- therapeutic use ✖Remove constraint Subjects: Antibodies, Monoclonal -- therapeutic use Titles Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value ✖Remove constraint Titles: Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

1. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):
Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick, author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
Subject(s):
Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

Refine by:

more »

  • Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value1